Dyslipidemia in childhood and adolescence: from screening to management. Issue 2 (25th April 2021)

• Record Type: Journal Article
• Authors: Yeung, Elizabeth; Daniels, Stephen R.; Patel, Sonali S.
• Is Part Of: Current opinion in endocrinology, diabetes and obesity. Volume 28:Issue 2(2021)
• Page Start: 152
• Page End: 158
• Publication Date: 2021-04-25
• Subjects: atherogenic -- dyslipidemia -- familial hypercholesterolemia -- hypertriglyceridemia -- hypertriglyceridemia -- lipoprotein(a) -- screening; Endocrinology -- Periodicals; Diabetes -- Periodicals; Obesity -- Periodicals; Diabetes Mellitus -- Periodicals; Endocrine System Diseases -- Periodicals; Endocrine Glands -- Periodicals; Obesity -- Periodicals; Endocrinologie -- Périodiques; Diabète -- Périodiques; Obésité -- Périodiques; Diabetes; Endocrinology; Obesity; Periodicals; 616.4
• DOI: 10.1097/MED.0000000000000607
• Languages: English
• ISSNs: 1752-296X

Abstract

Abstract : Purpose of review: To summarize types of dyslipidemia frequently encountered during childhood and adolescence, with a focus on screening, diagnosis, and management. Recent findings: It is important that screening for atherosclerotic cardiovascular disease (ASCVD) begin in childhood. Genetic testing allows for increased awareness of dyslipidemia and more targeted intervention. Pharmacologic treatment of pediatric dyslipidemias has a good safety profile and can reduce adult ASCVD risk. Summary: Much of what is known about pediatric dyslipidemia has been extrapolated from adult data, but recently, there have been increasing investigations within the pediatric population to better guide diagnosis and management of these disorders.